By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


SEARCH JOBS


Industry
Biotechnology






Company News
Ocular Therapeutix, Inc. (OCUL) Reports Fourth Quarter And Full Year 2014 Financial Results 3/10/2015 11:13:52 AM
Ocular Therapeutix, Inc. (OCUL) Reports Positive Topline Clinical Data For The First Of Two Phase 3 Clinical Trials Evaluating OTX-DP For The Treatment Of Post-Surgical Ocular Inflammation And Pain 3/10/2015 11:10:19 AM
Ocular Therapeutix, Inc. (OCUL) To Report Fourth Quarter And Full Year 2014 Financial Results 3/4/2015 11:10:02 AM
Ocular Therapeutix, Inc. (OCUL) To Participate In Two Upcoming Investor Conferences 2/19/2015 12:27:15 PM
Ocular Therapeutix, Inc. (OCUL) To Present At The 17th Annual BIO CEO & Investor Conference 2/5/2015 11:35:12 AM
Ocular Therapeutix, Inc. (OCUL) Enrolls First Patient In Phase 2 Clinical Trial For Sustained Release Dexamethasone For The Treatment Of Dry Eye Disease 1/21/2015 8:13:47 AM
Ocular Therapeutix, Inc. (OCUL) To Present At Oppenheimer 25th Annual Healthcare Conference 12/2/2014 3:10:19 PM
Ora-CAC® Model Provided Platform For Recent Positive Phase 2 Data For Ocular Therapeutix, Inc. (OCUL)’s OTX-DP In Allergic Conjunctivitis 11/24/2014 9:42:08 AM
Ocular Therapeutix, Inc. (OCUL) Enrolls First Patients In Phase 2b Clinical Trial For Sustained Release Travoprost For The Treatment Of Glaucoma And Ocular Hypertension 11/12/2014 10:29:24 AM
Ocular Therapeutix, Inc. (OCUL) Reports Third Quarter 2014 Financial Results 11/12/2014 9:52:55 AM
12345
//-->